Clinical trial
Pivotal Study in Advanced Parkinsons Disease Patients
NCT00466167 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00466167 |
|---|---|
| Title | Pivotal Study in Advanced Parkinsons Disease Patients |
| Official title | A Double-blind, Double-dummy, Placebo-controlled, Randomized, Three Parallel Groups Study Comparing the Efficacy, Safety and Tolerability of Pramipexole Extended Release (ER) Versus Placebo and Versus Pramipexole Immediate Release (IR) Administered Orally Over a 26-week Maintenance Phase in L-Dopa+… |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Drug |
| Interventions | Pramipexol Extended Release, Pramipexol Immediate Release, Placebo |
| Enrollment | 517 |
| Start date | Apr 1, 2007 |
| Primary completion | Nov 1, 2008 |
| First posted | Apr 27, 2007 |
| Last update posted | Jul 8, 2014 |
| Countries | Austria, Czechia, Hungary, India, Italy, Philippines, Poland, Russia, Slovakia, South Korea, Spain, Sweden and 2 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: